Satsuma Pharmaceuticals (STSA) Competitor Comparison
We are evaluating the key criteria listed to compare Satsuma Pharmaceuticals (STSA) against its competitors in the Biotechnology industry.
Market Capitalization
307 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
144 / 337Free Cashflow
151 / 352Quick Ratio
129 / 357Earnings per Share
207 / 359Dividend yield
0 / 6Total Cash
272 / 358Performance 3 years
345 / 368Performance 5 years
298 / 368Performance 10 years
265 / 368Linearity 3 years
312 / 368Linearity 5 years
220 / 368Linearity 10 years
180 / 367Total Rank
256 / 368Dividend Rank
22 / 368Valuation Rank
329 / 368Piotroski Rank
250 / 368Muliplier Rank
43 / 368Market Capitalization - STSA ranking 307 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.